DK0949907T3 - Fremgangsmåder og præparater til forbedret biotilgængelighed og biologisk aktive midler til slimhindeadministration - Google Patents
Fremgangsmåder og præparater til forbedret biotilgængelighed og biologisk aktive midler til slimhindeadministrationInfo
- Publication number
- DK0949907T3 DK0949907T3 DK97950343T DK97950343T DK0949907T3 DK 0949907 T3 DK0949907 T3 DK 0949907T3 DK 97950343 T DK97950343 T DK 97950343T DK 97950343 T DK97950343 T DK 97950343T DK 0949907 T3 DK0949907 T3 DK 0949907T3
- Authority
- DK
- Denmark
- Prior art keywords
- compositions
- methods
- biologically active
- active agents
- mucosal administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3397696P | 1996-12-31 | 1996-12-31 | |
PCT/GB1997/003557 WO1998029097A1 (en) | 1996-12-31 | 1997-12-31 | Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0949907T3 true DK0949907T3 (da) | 2003-07-14 |
Family
ID=21873566
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97950343T DK0949907T3 (da) | 1996-12-31 | 1997-12-31 | Fremgangsmåder og præparater til forbedret biotilgængelighed og biologisk aktive midler til slimhindeadministration |
Country Status (12)
Country | Link |
---|---|
US (1) | US6517860B1 (da) |
EP (1) | EP0949907B1 (da) |
JP (1) | JP2001507357A (da) |
AT (1) | ATE234607T1 (da) |
AU (1) | AU732347B2 (da) |
CA (1) | CA2275502A1 (da) |
DE (1) | DE69720045T2 (da) |
DK (1) | DK0949907T3 (da) |
ES (1) | ES2192705T3 (da) |
PT (1) | PT949907E (da) |
WO (1) | WO1998029097A1 (da) |
ZA (1) | ZA9711732B (da) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
US20030095926A1 (en) * | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
US20030185761A1 (en) | 1997-10-01 | 2003-10-02 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
US20040136914A1 (en) | 1997-10-01 | 2004-07-15 | Dugger Harry A. | Buccal, polar and non-polar spray containing ondansetron |
DE69738333T2 (de) | 1997-10-01 | 2008-11-27 | Novadel Pharma Inc. | Nichtpolares Spray zur bukkalen Verabreichung |
US20030077227A1 (en) | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
US6352722B1 (en) * | 1997-12-23 | 2002-03-05 | Quadrant Holdings Cambridge Limited | Derivatized carbohydrates, compositions comprised thereof and methods of use thereof |
ATE307808T1 (de) * | 1999-03-24 | 2005-11-15 | Scherer Technologies Inc R P | Pharmazeutische formulierungen mit verbesserter löslichkeit in wasser |
GB9916316D0 (en) * | 1999-07-12 | 1999-09-15 | Quadrant Holdings Cambridge | Dry powder compositions |
DE60142043D1 (de) | 2000-04-03 | 2010-06-17 | Battelle Memorial Inst Columbu | Ausgabevorrichtungen und flüssigformulierungen |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
GB0011807D0 (en) * | 2000-05-16 | 2000-07-05 | Quadrant Holdings Cambridge | Formulation for inhalation |
GB0020616D0 (en) * | 2000-08-21 | 2000-10-11 | Quadrant Holdings Cambridge | Particulates |
US6613308B2 (en) * | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
GB0024271D0 (en) * | 2000-09-25 | 2000-11-15 | Colaco Camilo | Improved methods and compositions for pulmonary delivery of actives |
MXPA03004883A (es) | 2000-12-01 | 2004-05-04 | Battelle Memorial Institute | Metodo para la estabilizacion de biomoleculas (por ejemplo, insulina) en formulaciones liquidas. |
GB0124710D0 (en) * | 2001-10-15 | 2001-12-05 | Quadrant Healthcare Uk Ltd | Therapeutic composition |
US7368102B2 (en) | 2001-12-19 | 2008-05-06 | Nektar Therapeutics | Pulmonary delivery of aminoglycosides |
JP4959919B2 (ja) * | 2001-12-21 | 2012-06-27 | スリーエム イノベイティブ プロパティズ カンパニー | 官能基を有するポリエチレングリコール賦形剤を用いた医薬用エアロゾル組成物 |
GB0208608D0 (en) * | 2002-04-13 | 2002-05-22 | Glaxo Group Ltd | Composition |
GB0210771D0 (en) * | 2002-05-10 | 2002-06-19 | Univ London Pharmacy | Derivatised particulate inhalation carriers |
EP1713514B1 (en) | 2004-01-28 | 2021-11-24 | Johns Hopkins University | Drugs and gene carrier particles that rapidly move through mucous barriers |
KR20050104152A (ko) | 2004-04-28 | 2005-11-02 | 최승호 | 경구용 약물의 흡수를 증진하는 약제학적 조성물 |
US20060147520A1 (en) * | 2004-07-26 | 2006-07-06 | Curtis Ruegg | Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation |
US7175858B2 (en) * | 2004-07-26 | 2007-02-13 | Skeletal Kinetics Llc | Calcium phosphate cements and methods for using the same |
EP1809252A2 (en) * | 2004-10-29 | 2007-07-25 | Presidents and Fellows of Harvard College | Particles for treatment of pulmonary infection |
WO2006066907A1 (en) * | 2004-12-21 | 2006-06-29 | Glaxo Group Limited | Pharmaceutical formulations |
US20070009564A1 (en) | 2005-06-22 | 2007-01-11 | Mcclain James B | Drug/polymer composite materials and methods of making the same |
US20090062909A1 (en) * | 2005-07-15 | 2009-03-05 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
US8298565B2 (en) | 2005-07-15 | 2012-10-30 | Micell Technologies, Inc. | Polymer coatings containing drug powder of controlled morphology |
GB2430880A (en) * | 2005-10-04 | 2007-04-11 | Cambridge Biostability Ltd | Pharmaceutical compositions stabilized in glassy particles |
GB0523638D0 (en) * | 2005-11-21 | 2005-12-28 | Cambridge Biostability Ltd | Pharmaceutical device for the administration of substances to patients |
ES2540059T3 (es) | 2006-04-26 | 2015-07-08 | Micell Technologies, Inc. | Recubrimientos que contienen múltiples fármacos |
CA2663003C (en) * | 2006-09-08 | 2018-02-13 | Justin Hanes | Compositions and methods for enhancing transport through mucus |
US8636767B2 (en) | 2006-10-02 | 2014-01-28 | Micell Technologies, Inc. | Surgical sutures having increased strength |
CN102886326A (zh) * | 2006-10-23 | 2013-01-23 | 米歇尔技术公司 | 用于在涂覆过程中为基底充电的保持器 |
JP5603598B2 (ja) | 2007-01-08 | 2014-10-08 | ミセル テクノロジーズ、インコーポレイテッド | 生物分解層を有するステント |
US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
AU2008242844A1 (en) * | 2007-04-17 | 2008-10-30 | Micell Technologies, Inc. | Stents having biodegradable layers |
WO2008148013A1 (en) * | 2007-05-25 | 2008-12-04 | Micell Technologies, Inc. | Polymer films for medical device coating |
WO2009051780A1 (en) * | 2007-10-19 | 2009-04-23 | Micell Technologies, Inc. | Drug coated stents |
EP3360586B1 (en) * | 2008-04-17 | 2024-03-06 | Micell Technologies, Inc. | Stents having bioabsorbable layers |
WO2011009096A1 (en) | 2009-07-16 | 2011-01-20 | Micell Technologies, Inc. | Drug delivery medical device |
CA2946195A1 (en) | 2008-07-17 | 2010-01-21 | Micell Technologies, Inc. | Drug delivery medical device |
US8834913B2 (en) * | 2008-12-26 | 2014-09-16 | Battelle Memorial Institute | Medical implants and methods of making medical implants |
EP2410954A4 (en) * | 2009-03-23 | 2014-03-05 | Micell Technologies Inc | PERIPHERAL STENTS WITH LAYERS |
WO2010111232A2 (en) * | 2009-03-23 | 2010-09-30 | Micell Technologies, Inc. | Drug delivery medical device |
WO2010111238A2 (en) * | 2009-03-23 | 2010-09-30 | Micell Technologies, Inc. | Improved biodegradable polymers |
CN102481195B (zh) | 2009-04-01 | 2015-03-25 | 米歇尔技术公司 | 涂覆支架 |
WO2010121187A2 (en) | 2009-04-17 | 2010-10-21 | Micell Techologies, Inc. | Stents having controlled elution |
US11369498B2 (en) | 2010-02-02 | 2022-06-28 | MT Acquisition Holdings LLC | Stent and stent delivery system with improved deliverability |
US8795762B2 (en) * | 2010-03-26 | 2014-08-05 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
WO2011133655A1 (en) | 2010-04-22 | 2011-10-27 | Micell Technologies, Inc. | Stents and other devices having extracellular matrix coating |
EP2397484A1 (en) * | 2010-06-11 | 2011-12-21 | Immunovo B.V. | Trisaccharide derivates, and their use as adjuvants |
EP2593039B1 (en) | 2010-07-16 | 2022-11-30 | Micell Technologies, Inc. | Drug delivery medical device |
US9636309B2 (en) | 2010-09-09 | 2017-05-02 | Micell Technologies, Inc. | Macrolide dosage forms |
WO2012166819A1 (en) | 2011-05-31 | 2012-12-06 | Micell Technologies, Inc. | System and process for formation of a time-released, drug-eluting transferable coating |
WO2013012689A1 (en) | 2011-07-15 | 2013-01-24 | Micell Technologies, Inc. | Drug delivery medical device |
US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
EP3808339A1 (en) | 2012-05-03 | 2021-04-21 | Kala Pharmaceuticals, Inc. | Pharmaceutical nanoparticles showing improved mucosal transport |
US11596599B2 (en) | 2012-05-03 | 2023-03-07 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
KR102140989B1 (ko) | 2012-05-03 | 2020-08-04 | 칼라 파마슈티컬스, 인크. | 개선된 점막 수송을 나타내는 제약 나노입자 |
US9827191B2 (en) | 2012-05-03 | 2017-11-28 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
JP6669499B2 (ja) | 2013-02-15 | 2020-03-18 | カラ ファーマシューティカルズ インコーポレイテッド | 治療用化合物 |
US9353123B2 (en) | 2013-02-20 | 2016-05-31 | Kala Pharmaceuticals, Inc. | Therapeutic compounds and uses thereof |
US9688688B2 (en) | 2013-02-20 | 2017-06-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof |
EP2967803B1 (en) | 2013-03-12 | 2023-12-27 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
US10272606B2 (en) | 2013-05-15 | 2019-04-30 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
CN106061261B (zh) | 2013-11-01 | 2018-04-24 | 卡拉制药公司 | 治疗化合物的结晶形式及其用途 |
US9890173B2 (en) | 2013-11-01 | 2018-02-13 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
WO2016067252A1 (en) | 2014-10-31 | 2016-05-06 | Glaxosmithkline Intellectual Property Development Limited | Powder formulation |
EP3509421A4 (en) | 2016-09-08 | 2020-05-20 | Kala Pharmaceuticals, Inc. | CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF |
AU2017324716B2 (en) | 2016-09-08 | 2020-08-13 | KALA BIO, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
US10253036B2 (en) | 2016-09-08 | 2019-04-09 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2037735B (en) | 1978-12-21 | 1983-11-09 | Standard Telephones Cables Ltd | Glass composition |
JPS60258195A (ja) | 1984-06-05 | 1985-12-20 | Ss Pharmaceut Co Ltd | α.α―トレハロース脂肪酸ジエステル誘導体 |
GB8508173D0 (en) | 1985-03-28 | 1985-05-01 | Standard Telephones Cables Ltd | Controlled delivery device |
IE63869B1 (en) | 1986-11-06 | 1995-06-14 | Res Dev Foundation | Aerosols containing liposomes and method for their preparation |
US5006343A (en) * | 1988-12-29 | 1991-04-09 | Benson Bradley J | Pulmonary administration of pharmaceutically active substances |
US5011678A (en) | 1989-02-01 | 1991-04-30 | California Biotechnology Inc. | Composition and method for administration of pharmaceutically active substances |
WO1990011756A1 (en) | 1989-04-12 | 1990-10-18 | Aberdeen University | Slow release vitreous systems |
US5270048A (en) | 1989-04-21 | 1993-12-14 | Borden (Uk) Limited | Controlled delivery devices |
GB9105705D0 (en) | 1991-03-18 | 1991-05-01 | Sandoz Ltd | Improvements in or relating to organic compounds |
GB9113872D0 (en) | 1991-06-27 | 1991-08-14 | Sandoz Ag | Improvements in or relating to organic compounds |
GB9204466D0 (en) | 1992-03-02 | 1992-04-15 | Sandoz Ltd | Improvements in or relating to organic compounds |
BR9307141A (pt) * | 1992-09-29 | 1999-03-30 | Inhale Therapeutic Syst | Processo para a liberação sistência pulsátil de um fragmento ativo de hormônio de paratiróide (PTH) para um hospedeiro mamífero e para um paciente e composição farmacêutica |
US5744155A (en) * | 1993-08-13 | 1998-04-28 | Friedman; Doron | Bioadhesive emulsion preparations for enhanced drug delivery |
US5591453A (en) | 1994-07-27 | 1997-01-07 | The Trustees Of The University Of Pennsylvania | Incorporation of biologically active molecules into bioactive glasses |
DE69531992T2 (de) * | 1994-08-04 | 2004-07-22 | Elan Drug Delivery Ltd., Ruddington | Feste verabreichungssysteme zur gesteuerten freisetzung von darin eingebauten molekülen sowie verfahren zu deren herstellung |
US5747001A (en) * | 1995-02-24 | 1998-05-05 | Nanosystems, L.L.C. | Aerosols containing beclomethazone nanoparticle dispersions |
-
1997
- 1997-12-30 US US09/000,857 patent/US6517860B1/en not_active Expired - Fee Related
- 1997-12-30 ZA ZA9711732A patent/ZA9711732B/xx unknown
- 1997-12-31 WO PCT/GB1997/003557 patent/WO1998029097A1/en active IP Right Grant
- 1997-12-31 DE DE69720045T patent/DE69720045T2/de not_active Expired - Fee Related
- 1997-12-31 AU AU53338/98A patent/AU732347B2/en not_active Ceased
- 1997-12-31 CA CA002275502A patent/CA2275502A1/en not_active Abandoned
- 1997-12-31 JP JP52975098A patent/JP2001507357A/ja active Pending
- 1997-12-31 EP EP97950343A patent/EP0949907B1/en not_active Expired - Lifetime
- 1997-12-31 ES ES97950343T patent/ES2192705T3/es not_active Expired - Lifetime
- 1997-12-31 AT AT97950343T patent/ATE234607T1/de not_active IP Right Cessation
- 1997-12-31 PT PT97950343T patent/PT949907E/pt unknown
- 1997-12-31 DK DK97950343T patent/DK0949907T3/da active
Also Published As
Publication number | Publication date |
---|---|
WO1998029097A1 (en) | 1998-07-09 |
ZA9711732B (en) | 1998-12-28 |
EP0949907B1 (en) | 2003-03-19 |
PT949907E (pt) | 2003-07-31 |
DE69720045D1 (de) | 2003-04-24 |
US6517860B1 (en) | 2003-02-11 |
EP0949907A1 (en) | 1999-10-20 |
ES2192705T3 (es) | 2003-10-16 |
DE69720045T2 (de) | 2003-09-04 |
AU5333898A (en) | 1998-07-31 |
ATE234607T1 (de) | 2003-04-15 |
JP2001507357A (ja) | 2001-06-05 |
CA2275502A1 (en) | 1998-07-09 |
AU732347B2 (en) | 2001-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0949907T3 (da) | Fremgangsmåder og præparater til forbedret biotilgængelighed og biologisk aktive midler til slimhindeadministration | |
PT910339E (pt) | Aerossol polar bucal | |
ATE460921T1 (de) | Medikamenthaltige zusammensetzung in aerosolform | |
FI962154A0 (fi) | Koostumus terapeuttisten tuotteiden in vivo valmistusta varten | |
IL140930A0 (en) | Compounds and compositions for delivering active agents | |
NZ287857A (en) | Delivery of water insoluble active agents using tocopherol as emulsifier or solvent | |
DE69928006D1 (de) | Lagerstabile flüssige zusammensetzungen von glucagon-ähnlichem peptid-1 | |
MY129356A (en) | Electrospun pharmaceutical compositions | |
BR0008590A (pt) | Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto | |
HK1058902A1 (en) | Compositions for protein delivery via the pulmonary route | |
SE0102843L (sv) | Stabiliserad oral farmaceutisk komposition innehållande jodid och jodat och metod | |
IL161500A0 (en) | Taste masking spill-resistant formulation | |
ATE89750T1 (de) | Pharmazeutische zusammensetzungen. | |
WO2002043706A3 (en) | Prolamin-based sustained-release compositions and delayed-onset compositions | |
HK1022265A1 (en) | Biodegradable microparticles for the sustained delivery of therapeutic drugs | |
MY131488A (en) | Low dose liquid entecavir formulations and use | |
MXPA03002807A (es) | Estabilizacion de formulaciones solidas de farmacos. | |
PL348202A1 (en) | Pharmaceutically active composition and dispensing device | |
HRP20000781B1 (en) | Effervescent preparations | |
SE9403389D0 (sv) | Pharmaceutical composition containing derivattves of sex hormones | |
WO2003028624A3 (en) | Levothyroxine compositions and methods | |
ATE380543T1 (de) | Stabilisierung von festen schilddrüsenhormonzusammensetzungen | |
AU1174400A (en) | Retro-inversion peptides that target git transport receptors and related methods | |
WO2003013441A3 (en) | Levothyroxine compositions and methods | |
NZ510446A (en) | Gastrointestinal delivery of LH-RH peptide analogues |